The effectiveness of immune checkpoint inhibitors in the neoadjuvant and post-neoadjuvant breast cancer settings
1Yale School of Medicine, New Haven, Connecticut.
Clinical Advances in Hematology & Oncology : H&O
|September 20, 2022
Abstract
No abstract available in PubMed .


